Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06377982

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy

A Phase I, Randomized, Double-blind, Placebo-controlled Clinical Study to Assess the Safety and Efficacy of Allogeneic Human Umbilical Cord Blood Infusion in Children with Cerebral Palsy

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
12 (estimated)
Sponsor
StemCyte Taiwan Co., Ltd. · Industry
Sex
All
Age
1 Year – 18 Years
Healthy volunteers
Not accepted

Summary

A phase I, randomized, double-blind, placebo-controlled clinical study to assess the safety and efficacy of allogeneic human umbilical cord blood infusion in children with cerebral palsy

Detailed description

This is a phase I study to evaluate the safety and efficacy in hUCB treatment on the patients with cerebral palsy (CP).

Conditions

Interventions

TypeNameDescription
BIOLOGICALhUCBhUCB

Timeline

Start date
2025-09-01
Primary completion
2027-09-01
Completion
2028-12-01
First posted
2024-04-22
Last updated
2025-02-27

Source: ClinicalTrials.gov record NCT06377982. Inclusion in this directory is not an endorsement.

Human Umbilical Cord Blood Infusion in Patients with Cerebral Palsy (NCT06377982) · Clinical Trials Directory